164 results
Page 2 of 9
6-K
EX-99.2
32w 48rwrbels
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
i8m2 gxvnu0
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
qvhrbvv
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
54q0 fm951n
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
poh oco8ak7o
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.4
sef3er5
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
3luvvewcqk 8s
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
xyt6elg
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.4
01zfzsrv swwn
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
4jvggdnh
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
dsbz042q4n
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
vzg0kqn ai
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
z9q31 071v
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
11vyj hf2
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
enxnfpt0
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.2
utl33
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.2
g2ysr
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
r45bt
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
ct902gzlq8h5scgz
21 Oct 21
Current report (foreign)
3:49pm